Monopar Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $190k | 2.3k | 81.67 |
| 2025-06-30 | $82k | 2.3k | 35.78 |
| 2025-03-31 | $9.1k | 250 | 36.41 |
| 2024-12-31 | $5.5k | 250 | 22.00 |
| 2024-09-30 | $3.4k | 500 | 6.74 |